Retrospective Evaluation of Intravenous Oxyhydrogen Nanobubble Therapy in Chronic Kidney Disease
In 47 patients with CKD, following HHO therapy, 61.7% of patients showed improved eGFR, particularly those in CKD Stage III. These findings add human evidence supporting molecular hydrogen's therapeutic potential across the specific human outcomes evaluated in this study.
Read Article